Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression (NCT07211438)
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
Psilocybin, the chemical component of "magic mushrooms", has been administered with psychological support in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to determine the role of psilocybin monitors on the effects of psilocybin therapy in adults with treatment resistant depression.
Who can join: Review the eligibility criteria below.
Location: Toronto Western Hospital (University Health Network) — Toronto, Ontario
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Toronto Western Hospital (University Health Network) — Toronto, Ontario
- Centre for Addiction and Mental Health — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (416) 535-8501
Email: emily.gilbert@camh.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Treatment-Resistant Depression
- Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression — Tulsa, Oklahoma
- Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression — Toronto, Ontario
- Physical Activity Program for TRD — Toronto, Ontario
- Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression — Toronto, Ontario
Explore by condition: All Treatment-Resistant Depression clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.